This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Elsevier To Market Stanson Health CDS System, Complementing Elsevier's Broad Portfolio Of Clinical Workflow Solutions

PHILADELPHIA, April 23, 2014 /PRNewswire/ --

 

Stanson's next-generation clinical decision support and analytics solution fully integrates into EMRs, provides alerts to help providers keep care costs low, quality high  

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today an agreement to market Stanson Health's next-generation clinical decision support (CDS) and analytics solution. Stanson's CDS solutions are designed to safely reduce the cost and potential for harm from unnecessary care by leveraging user-friendly, real-time alerts and analytics to help guide physicians' decisions.

Stanson's CDS solutions complement the Elsevier Clinical Solutions suite, which includes a portfolio of solutions for workflow and decision support, clinical reference and drug reference, patient engagement and performance management.

As the healthcare industry evolves, healthcare payers (i.e., insurance companies, the government) are counting on physicians and hospitals to control and even reduce costs as they improve the quality of care. Unnecessary or inappropriate care accounts for a significant amount of the overall healthcare spend, and more than 80 percent of overall healthcare costs are directly linked to decisions made by physicians.

Stanson Health, a population health, CDS and analytics company, provides previously tested and validated CDS alerts, which reduce the potential for "false positive" alerts that cause alert fatigue. The alerts are designed to reduce unnecessary care for patient populations across the continuum, in physician offices, emergency departments and hospitals. The CDS recommendations are based on widely accepted guidelines, including from Choosing Wisely®, an initiative of the ABIM Foundation. The analytics solution provides comparative information on physician acceptance and rejection of CDS recommendations and provides "utilization fingerprints" that are used to inform discussions about high quality and cost-effective care.

"With the transition toward population health and payment reform, and the improvement in EHR functionality, we believe that there is need for the next generation of CDS," said Scott Weingarten, MD, Chairman of Stanson Health. "The CDS should be integrated into the workflow, personalized for each patient, accompanied by analytics and tested prior to release to reduce false-positives, impact care across the continuum, safely reduce costs and improve quality."

Weingarten was the co-founder and CEO of Zynx Health for 16 years. Stanson Health's CDS and analytics solution was first implemented at Cedars-Sinai Health System, where it demonstrated statistically significant improvements in the quality of patient care and reductions in inappropriate care.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs